NCT03292419 is a NA clinical trial of Topography-guided LASIK in Myopia, sponsored by Stanford University.

Who is sponsoring NCT03292419?

NCT03292419 is sponsored by Stanford University.

What drugs are being tested in NCT03292419?

Interventions in NCT03292419: Topography-guided LASIK.

Is NCT03292419 still recruiting?

NCT03292419 is currently completed. Last updated 5 April 2022.

Last reviewed 2022-04-05 · How we verify

NCT03292419

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Topography-guided LASIK Surgery

Completed NA Last updated 5 April 2022

What this trial tests

NA trial testing Topography-guided LASIK in Myopia in 30 participants. Completed in 31 March 2022.

Timeline

1 June 2018

Primary endpoint
30 June 2021

31 March 2022

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 June 2018
Primary completion	30 June 2021
Estimated completion	31 March 2022
Sites	1 location across United States

Drugs / interventions tested

Topography-guided LASIK

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

Stanford University

Who can join

Adults 18 to 59, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are analyzing outcomes of topography-guided LASIK surgery in participants with myopia and myopic astigmatism

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Topography-guided LASIK

Trials testing the same drug.

NCT03075176 — Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy · NA · terminated

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03292419 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 5 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03292419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing